Minerva Surgical Inc (UTRS) Financials

$0.00

$-0.65 (-99.98%)

As on 04-Sep-2026 09:30EDT

Market cap

$0 Mln

Revenue (TTM)

$52 Mln

P/E Ratio

--

P/B Ratio

0

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Operating Revenue	51.69	50.29	52.10	37.77	26.01	--
Cost of Revenue	23.69	23.05	21.58	18.65	14.21	--
Gross Profit	28.01	27.24	30.52	19.12	11.81	--
Operating Expenses	57.26	58.14	59.67	34.51	31.44	--
Operating Profit (EBIT)	-29.26	-30.90	-29.15	-15.39	-19.64	--
Other Income	0.18	--	-21.29	--	--	--
Profit before Tax	-33.40	-34.10	-21.46	-18.40	-52.05	--
Provision for Tax	0.06	0.01	0.01	-0.13	17.75	--
Profit after Tax (Net Income)	-35.55	-34.11	-21.46	-18.26	-52.05	--
Minority Interest	--	--	--	--	--	--
Consolidated Profit	-26.27	-34.11	-21.46	-18.26	-52.05	--

Liabilities ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Shareholder's Funds	20.26	17.18	44.10	-221.81	-204.52	--
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	31.28	37.44	48.37	280.59	235.99	--
Current Liabilities	21.25	14.28	22.81	33.27	15.22	--
Total Liabilities	94.04	68.90	115.09	92.05	46.68	--

Assets ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Non-Current Assets	32.78	32.78	40.09	46.63	2.87	--
Current Assets	40.00	36.12	75.00	45.42	43.81	--
Total Assets	94.04	68.90	115.09	92.05	46.68	--
Total Debt*	43.55	39.69	39.27	97.29	75.89	--
Net Current Assets	18.75	21.84	52.38	12.15	28.59	--

Cashflow ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Cash From Operating Activities	--	-35.57	-22.38	-12.24	-19.79	--
Cash Flow from Investing Activities	--	-0.07	-25.58	-15.45	-0.22	--
Cash from Financing Activities	--	-4.96	71.21	18.08	43.16	--
Net Cash Inflow / Outflow	--	--	23.25	--	--	--

Financials Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Adjusted EPS ($)	-4.81	-1.15	-14.89	-17.90	--	--
Cash EPS ($)	--	-0.79	-7.52	-10.97	--	--
Adjusted Book Value ($)	--	0.58	30.60	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-1.20	-15.53	-12.00	--	--
Free Cash Flow per Share ($)	--	-1.21	-15.93	-12.45	--	--

Profitability Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
ROCE (%)	--	-48.64	104.33	14.43	--	--
ROE (%)	-130.88	-111.32	24.16	8.57	--	--
ROA (%)	-35.40	-37.08	-20.72	-26.33	--	--
EBIT Margin (%)	-56.07	-61.40	-18.67	-16.56	-75.49	--
Net Margin (%)	-68.53	-67.83	-69.65	-48.36	-200.08	--
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Revenue Growth (%)	3.11	-0.03	0.38	0.45	--	--
EBIT Growth (%)	-110.27	-217.46	-55.51	68.15	--	--
Net Profit Growth (%)	-93.23	-58.93	-17.53	64.91	--	--
EPS Growth (%)	62.86	0.92	0.17	--	--	--
Book Value Growth (%)	-84.84	--	--	--	--	--

Valuation Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Price / Earnings	--	-0.19	-0.35	--	--	--
Price / Book Value	--	0.38	0.17	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-24.21	-1.96	6.80	--	--	--
Close Price ($)	3.30	4.46	102.80	--	--	--
High Price ($)	17.68	124.00	240.00	--	--	--
Low Price ($)	3.00	3.00	85.60	--	--	--
Market Cap ($ Cr)	0.00	--	--	--	--	--

Solvency Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debt to Equity	1.38	2.31	0.89	-0.44	-0.37	--
Short term debt to equity ratio	0.61	0.13	0.00	-0.01	--	--
Current Ratio	1.88	2.53	3.29	1.37	2.88	--
Quick Ratio	1.03	1.35	2.60	1.06	2.57	--
Interest Coverage	-6.60	-9.58	-0.83	-0.52	-1.12	--

Operating Efficiency Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debtors to sales (%)	14.64	14.40	14.00	22.19	15.17	--
Asset Turnover	0.51	0.55	0.50	0.54	--	--
Receivable days	--	52.78	54.93	59.60	55.42	--
Inventory Days	--	257.73	219.04	146.36	121.96	--
Payable days	--	50.96	60.38	75.40	107.80	--
Cash Conversion Cycle	--	259.55	213.59	130.56	69.59	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.